KOE:290650
L&C Bio Co., Ltd · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:50 UTC
Last close
n/aKRW
Market data
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
1.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-161.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-3.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.47Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
What it pays out is the furthest below its sector's middle: 0.04 against 0.36 on the market's range.
Follow one won
lens 1 of 9The five stops
5 of 5 read- After what it costs to make41,324,961,00048.4%
- After running the business3,441,320,0004.0%
- After interest and tax-138,174,717,000-162%
- After what it must reinvest-3,245,301,000-3.8%
- Kept after the dividend-4,367,775,000-5.1%
Of every unit of sales, -0.05 is still there after the dividend.
Of every unit of sales, -0.05 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales85,476,415,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After what it costs to make41,324,961,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After running the business3,441,320,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After interest and tax-138,174,717,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
After what it must reinvest-3,245,301,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Kept after the dividend-4,367,775,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW